There are currently 1267 clinical trials in Miami, Florida looking for participants to engage in research studies. Trials are conducted at various facilities, including University of Miami, GSK Investigational Site, University of Miami Miller School of Medicine-Sylvester Cancer Center and University of Miami Miller School of Medicine. Whether you're a healthy volunteer looking to participate in paid medical research or seeking trials related to a specific condition, the city provides a diverse range of opportunities near you.
Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT05850689
Recruiting
This is a multicenter, randomized, double-blind, placebo-controlled parallel-group, fixed-dose study in patients with a primary diagnosis of MDD according to criteria of the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) who have an inadequate response to ongoing ADT.
Gender:
ALL
Ages:
Between 18 years and 65 years
Trial Updated:
10/30/2024
Locations: Clinical Site, Miami, Florida +2 locations
Conditions: Major Depressive Disorder
Register for Updates
The Efficacy of Distal Pharyngeal Airway for Oxygenation During TEE
NCT05974488
Recruiting
The purpose of this study is to investigate the effect of using the McMurray Enhanced Airway (MEA) which is a flexible extended-length distal pharyngeal airway on improving oxygen delivery compared to standard nasal cannula.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/28/2024
Locations: Jackson Memorial Hospital, Miami, Florida
Conditions: Airway Obstruction
Register for Updates
Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
NCT05352672
Recruiting
This study is researching an experimental drug called REGN3767, also known as fianlimab (R3767), when combined with another medication called REGN2810, also known as cemiplimab (each individually called a "study drug" or called "study drugs" when combined). The study is focused on patients with a type of skin cancer known as melanoma. The aims of the study are to see how effective the combination of fianlimab and cemiplimab are in treating the melanoma skin cancer, in comparison with a medicati... Read More
Gender:
ALL
Ages:
12 years and above
Trial Updated:
10/28/2024
Locations: Miami Cancer Institute, Miami, Florida
Conditions: Melanoma
Register for Updates
(Neo)Adjuvant IDE196 (Darovasertib) in Patients With Localized Ocular Melanoma
NCT05907954
Recruiting
Neoadjuvant/adjuvant IDE196 (darovasertib) in patients with primary uveal melanoma
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/24/2024
Locations: University of Miami, Miami, Florida
Conditions: Uveal Melanoma
Register for Updates
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
NCT06145035
Recruiting
This is a Phase IIA, randomized, double blind, placebo controlled, multicenter study designed to assess the safety, feasibility, and efficacy of umbilical cord derived mesenchymal stromal cells (UC MSCs), administered intravenously (IV) as a single dose or repeated doses, in patients with ischemic cardiomyopathy (ICM).
Gender:
ALL
Ages:
Between 21 years and 85 years
Trial Updated:
10/23/2024
Locations: University of Miami Miller School of Medicine, Miami, Florida
Conditions: Ischemic Heart Disease
Register for Updates
ctDNA-Guided Sunitinib And Regorafenib Therapy for GIST
NCT05366816
Recruiting
The purpose of this research is to test if mutations (changes in DNA) in exons (segment of DNA or RNA containing information that has the instructions for making proteins) in the KIT gene can be used to predict the body's response to standard of care treatment.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/23/2024
Locations: University of Miami, Miami, Florida
Conditions: Gastrointestinal Stromal Tumors
Register for Updates
Administration of Allogeneic-MSC in Patients with Non-Ischemic Dilated Cardiomyopathy
NCT04476901
Recruiting
The purpose of this study is to evaluate the safety and effectiveness of an experimental drug called human allogeneic mesenchymal stem cell therapy.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
10/21/2024
Locations: University of Miami Miller School of Medicine, Miami, Florida
Conditions: Non-ischemic Dilated Cardiomyopathy
Register for Updates
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
NCT05766813
Recruiting
This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group, fixed-dose study in patients with a diagnosis of Parkinson's Disease consistent with the UK Parkinson's Disease Society (UKPDS) Brain Bank diagnostic criteria, who are experiencing wearing off symptoms and levodopa-induced dyskinesia.
Gender:
ALL
Ages:
40 years and above
Trial Updated:
10/21/2024
Locations: Clinical Site, Miami, Florida
Conditions: Parkinson Disease
Register for Updates
Striving Towards EmPowerment and Medication Adherence R01
NCT06463886
Recruiting
This is a study for Black women living with HIV to test a counseling program for Black women living with HIV. This participant may be a good fit if the participant is a Black woman, living with HIV, has a history of trauma, and is currently taking Antiretroviral Therapy (ART) medicines
Gender:
FEMALE
Ages:
18 years and above
Trial Updated:
10/19/2024
Locations: University of Miami, Miami, Florida
Conditions: Hiv, Mental Health Issue
Register for Updates
Characterization of 18F-Fluciclovine PET Amino Acid Radiotracer in Resected Brain Metastasis
NCT05554302
Recruiting
This study is for patients who have had surgery to remove brain metastasis and are planned to have stereotactic radiosurgery (SRS) after their brain surgery. It will be optional for patients to have a pre-surgery 18F-Fluciclovine PET/CT scan. The goal of the study is to determine whether a specific imaging agent, known as 18F-Fluciclovine, will help physicians evaluate the extent of surgery and determine if there is any visible tumor above what MRI alone can identify as well as improve the physi... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/17/2024
Locations: Miami Cancer Institute at Baptist Health South Florida, Miami, Florida
Conditions: Brain Metastases, Brain Cancer
Register for Updates
Integration of Neurocognitive Biomarkers Into a Neuro-Oncology Clinic
NCT05504681
Recruiting
This is prospective observational registry study that will assess 1) if the neurocognitive function app (Brainlab Cognition) can be used in a widespread neuro-oncology clinic setting and 2) if patient reported quality of life parameters can be obtained electronically and integrated into clinic.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/17/2024
Locations: Miami Cancer Institute, Miami, Florida
Conditions: Neurocognitive Disorders
Register for Updates
Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column
NCT04802603
Recruiting
This study is being done to determine the feasibility and tolerability of a novel regimen of spine stereotactic radiosurgery (SSRS). SSRS delivers high doses of radiation to tumors of the spine using precision techniques. In standard medical care, conventional SSRS is delivered in only 1 or 2 treatments. When this treatment is delivered in only 1-2 treatments, a high dose is used which can increase the side effects of treatment. This study aims to test an alternative technique of delivering SSR... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
10/17/2024
Locations: Miami Cancer Institute at Baptist Health, Inc, Miami, Florida
Conditions: Spine Metastases, Metastasis Spine
Register for Updates